Browsing Tag
FTSE 250
48 posts
Can Drax Group turn Bluefield Solar Income Fund into a post-biomass growth engine?
Drax is buying renewables scale. The harder question is whether Bluefield Solar can offset biomass risk and reset investor confidence.
GB Group (LSE: GBG) stock slides as FY26 results expose the cost of its AI identity platform reset
GB Group plc is betting on GBG Go after FY26 results, but investors are watching margins and debt. Find out what comes next.
Ocado Group (OCDO) stock jumps as Asda ecommerce deal gives UK grocery tech model a fresh test
Ocado Group plc has won a major Asda ecommerce deal. Find out why the partnership could reshape UK online grocery and OCDO sentiment today!
Why Apollo’s Bodycote proposal is another warning sign for UK industrial stocks
Apollo’s Bodycote proposal exposes the UK industrial valuation gap. Read why private equity is circling London-listed specialists.
Spire Healthcare (LSE: SPI) takeover talks: Why Toscafund’s 250p bid could reshape the UK private hospital investment case
Spire Healthcare found a buyer before the market found conviction. Toscafund’s 250p approach now tests UK healthcare valuation logic.
GB Group plc (LSE: GBG) says FY26 was in line, so why does the update still matter for investors?
GB Group plc says FY26 was in line as growth accelerated in H2. Read what GBG’s platform push, buybacks, and FY27 outlook could mean next.
Volex (AIM: VLX) upgrades FY2026 revenue to at least $1.22bn as AI data centre demand doubles and board eyes Main Market move
Volex (AIM: VLX) upgrades FY2026 revenue to $1.22bn, beats margin targets on AI data centre surge, and eyes London Main Market listing. Read the full analysis.
HICL Infrastructure (LSE: HICL) to sell A63 Motorway stake for £311m at 21% premium to book value
HICL Infrastructure to sell its A63 Motorway stake for £311m at a 21% premium to book, pushing total disposals past £1bn. Read our full analysis.
Bridgepoint and Triton walk away from Spire Healthcare (LSE: SPI) as board keeps formal sale process alive with remaining bidders
Bridgepoint and Triton have walked away from Spire Healthcare's sale process. Find out what it means for SPI shareholders and what happens next. Read more.
J D Wetherspoon (LSE: JDW) H1 FY26 results: Profit drops 32% as wage and tax costs weigh on hospitality sector outlook
J D Wetherspoon (JDW) H1 FY26: profit down 32% as costs surge. Revenue up 5.7%. Wetherspoon outperforms sector for 42 months. Read the full analysis.